FDA approves first RSV vaccine for adults after 60 years in the making

Photo caption: RSV leads to approximately 60,000 to 120,000 hospitalizations and 6,000 to 10,000 deaths among adults 65 years of age and older every year. Photo credit: Deposit Photos. Article by Laura Baisas. Popular Science – May 4, 2023. 

After 60 years of trial and error, the Food and Drug Administration (FDA) approved the first vaccine to prevent respiratory syncytial virus (RSV) on May 3. More preventative shots for the respiratory virus are on the way. The FDA approved Arexvy from pharmaceutical company GSK. […]

Click here to view original web page at www.popsci.com